Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

被引：0
|
作者：
Gunilla Journath
Kristina Hambraeus
Emil Hagström
Billie Pettersson
Mickael Löthgren
机构：
[1] Karolinska University Hospital,Cardiology unit, Department of Medicine, Karolinska Institutet
[2] Falun Hospital,Department of Cardiology
[3] Uppsala University,Uppsala Clinical Research Center, and Department of Medical Sciences
[4] Amgen Inc,undefined
[5] Thousand Oaks,undefined
[6] Amgen (Europe) GmbH,undefined
来源：
BMC Cardiovascular Disorders | / 17卷
关键词：
Cardiovascular disease; Costs; Guidelines; Lipids; Myocardial infarction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
    Journath, Gunilla
    Hambraeus, Kristina
    Hagstrom, Emil
    Pettersson, Billie
    Lothgren, Mickael
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [2] Lipid Lowering Therapy for Atherosclerotic Cardiovascular Disease: It Is Not So Simple
    Vincent, John
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (02) : 220 - 224
  • [3] The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence
    Adam, Safwaan
    Ho, Jan Hoong
    Bashir, Bilal
    Iqbal, Zohaib
    Ferdousi, Maryam
    Syed, Akheel A.
    Soran, Handrean
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (04) : 231 - 243
  • [4] Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease
    Cannon, Christopher P.
    Khan, Irfan
    Klimchak, Alexa C.
    Sanchez, Robert J.
    Sasiela, William J.
    Massaro, Joseph M.
    D'Agostino, Ralph B., Sr.
    Reynolds, Matthew R.
    AMERICAN HEART JOURNAL, 2019, 216 : 30 - 41
  • [5] Impact of Lipid Lowering Therapies on the Primary Prevention of Atherosclerotic Cardiovascular Disease
    Akruti P. Prabhakar
    Deepak Vedamurthy
    Dinesh K. Kalra
    Current Cardiovascular Risk Reports, 2025, 19 (1)
  • [6] Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease
    Cannon, Christopher P.
    Khan, Irfan
    Klimchak, Alexa C.
    Reynolds, Matthew R.
    Sanchez, Robert J.
    Sasiela, William J.
    JAMA CARDIOLOGY, 2017, 2 (09) : 959 - 966
  • [7] Adherence to Lipid Lowering Therapy among US Veterans with Atherosclerotic Cardiovascular Disease
    Ward, Rachel
    Wellman, Helen
    Yel, Nedim
    Young, Melissa
    Coleman-Lopez, Mason
    Niu, Xiaoli
    McElligott, Sean
    Gagnon, David
    Djousse, Luc
    Gaziano, Michael
    CIRCULATION, 2024, 150
  • [8] Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
    Bi, Lei
    Yi, Jiayi
    Wu, Chaoqun
    Hu, Shuang
    Zhang, Xingyi
    Lu, Jiapeng
    Liu, Jiamin
    Zhang, Haibo
    Yang, Yang
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Guo, Yuanlin
    Li, Xi
    Zheng, Xin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [9] Simulation of Impact on Cardiovascular Events With Lipid-lowering Treatment Intensification in Patients With Atherosclerotic Cardiovascular Disease in the US
    Khan, Irfan
    Cannon, Christopher P.
    Klimchak, Alexa
    Reynolds, Matthew R.
    Sanchez, Robert J.
    Sasiela, William J.
    CIRCULATION, 2016, 134
  • [10] Lipid-lowering therapy for the prevention of atherosclerotic cardiovascular disease: guidelines and clinical practice
    Lucchi, Tiziano
    Cesari, Matteo
    Vergani, Carlo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (04) : 256 - 263
12345